CVRx, Inc.

NASDAQ:CVRX

Medical - Devices

Healthcare
$2.63 +2.28%

+$0.11 today

Market cap
$69.79M
Beta
0.77
P/E (TTM)
-2.5
EPS (TTM)
-$2.00
52W Low $4.37High $11.30

Volume 0.37M

Average 0.30M

CVRX Other Income / Expenses

Net non-operating gains and losses, such as investment results, currency effects, and one-off items.

CVRx, Inc.NASDAQ: CVRX

Other Income / Expenses · Q1 FY2026 · quarter ended Mar 2026

Other income / expenses remains negative

Q1 FY2026 other income / expenses was -$958K, compared with -$334K a year earlier. Trailing-twelve-month other income / expenses was -$2.68M.

Context

  • Other income / expenses amounted to 3.6% of revenue in FY2025, up 2.8 pp from a year earlier.
  • Other income / expenses increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly other income / expenses holds near -$958K or moves back toward the trailing-twelve-month quarterly average of -$670.75K.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$958K-26.6% QoQ
Last fiscal yearDec 2025
-$2.06M-390.2% YoY
LTMMar 2026
-$2.68M-220.2% YoY
Other Income / Expenses past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-186.8%——
1 year-390.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Income / Expenses history

USD · from the income statement

Latest · FY2025
(2.06M) USD
Year-over-year change
-390.2%

Other Income / Expenses vs competitors

How CVRX compares with its peers on the latest reported figures

  • Peers report in different currencies, so other income / expenses is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -220.2% is the 7th highest of 10, against a peer median of -5.1%.
  • Other income / expenses amounts to 4.5% of revenue for CVRX, versus a peer median of 6.3%.
CVRX Competitors
Other Income / Expenses for CVRX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
QTRXQuanterix CorporationLTM Mar 2026$13.42M USD+0.9%—9.3%
SNWVSANUWAVE Health, Inc.LTM Mar 2026$13.3M USD+133.3%—30.0%
CERSCerus CorporationLTM Mar 2026$8.5M USD+893.5%—3.8%
PRQRProQR Therapeutics N.V.LTM Mar 2026€840.44K EUR-70.3%+16.3%6.3%
SENSSenseonics Holdings, Inc.LTM Mar 2026-$492K USD+87.4%—1.2%
SGHTSight Sciences, Inc.LTM Mar 2026-$1.62M USD-403.6%—2.0%
VMDViemed Healthcare, Inc.LTM Mar 2026-$1.92M USD-5.1%+12.7%0.7%
CVRXCVRx, Inc.LTM Mar 2026-$2.68M USD-220.2%—4.5%
MASS908 Devices Inc.LTM Mar 2026-$5.01M USD-234.1%—8.7%
NNOXNano-X Imaging Ltd.LTM Dec 2025-$16.11M USD-661.0%—123.7%
Peer median (excluding CVRX) —-5.1%+14.5%6.3%

Competitors are the stored peer set for CVRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue13.04M22.47M39.3M51.29M56.65M
Cost of Revenue3.64M5M6.26M8.33M8.31M
Gross Profit9.4M17.47M33.04M42.96M48.34M
Gross Margin72.1%77.8%84.1%83.8%85.3%
Research & Development7.5M9.95M11.63M11.13M11.13M
Selling, General & Admin27.86M50.05M64.51M91.32M88.47M
Operating Expenses35.36M60M76.14M102.45M99.61M
Depreciation & Amortization168K412K522K619K756K
EBITDA(40.6M)(40.74M)(38.73M)(54.89M)(46.74M)
EBITDA Margin-311.4%-181.3%-98.6%-107.0%-82.5%
Operating Income(25.97M)(42.53M)(43.1M)(59.49M)(51.27M)
Operating Margin-199.2%-189.3%-109.7%-116.0%-90.5%
Interest Income00000
Interest Expense2.22M165K1.8M4.4M5.83M
Other Income / Expenses(17.02M)1.21M2.05M(420K)(2.06M)
Income Before Tax(42.99M)(41.32M)(41.05M)(59.91M)(53.32M)
Pre-Tax Margin-329.8%-183.9%-104.5%-116.8%-94.1%
Income Tax Expense91K109K147K55K(18K)
Net Income(43.08M)(41.43M)(41.2M)(59.97M)(53.31M)
Net Margin-330.5%-184.4%-104.8%-116.9%-94.1%
EPS (Basic)(2.11)(2.02)(1.99)(2.65)(2.04)
EPS (Diluted)(2.11)(2.02)(1.99)(2.65)(2.04)
Weighted Avg Shares20.72M20.51M20.7M22.6M26.08M
Weighted Avg Shares (Diluted)20.72M20.53M20.75M22.6M26.08M

CVRx, Inc.

NASDAQ:CVRX

Intrinsic Alpha fair value

Locked

Current Price

$2.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.